FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054210 [Registered on: 20/06/2023] Trial Registered Prospectively
Last Modified On: 21/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [LEECH THERAPY]  
Study Design  Other 
Public Title of Study   An open labelled non randomized phase II clinical trial to evaluate the efficacy of leech therapy in siddha in the management of osteoarthritis 
Scientific Title of Study   An open labelled non randomized phase II clinical trial to evaluate the efficacy of attaividal (leech therapy in siddha external therapy) in the management of azhal keel vayu(Osteoarthritis) 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr R Shanmu 
Designation  PG scholar  
Affiliation  Government siddha medical colege and hospital  
Address  II year pg scholar Department of Pura Maruthuvam, Government siddha medical College and hospital, Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone    
Fax    
Email  vishnu31190@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr G Ganesan 
Designation  Lecturer Grade II 
Affiliation  Government siddha medical College and hospital, palayamkottai  
Address  Department of Pura Maruthuvam, Government siddha medical College and hospital, Palayamkottai Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9842474166  
Fax    
Email  ganesangabriel@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr G Ganesan 
Designation  Lecturer Grade II 
Affiliation  Government siddha medical College and hospital, palayamkottai  
Address  Department of Pura Maruthuvam, Government siddha medical College and hospital, Palayamkottai Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9842474166  
Fax    
Email  ganesangabriel@gmail.com  
 
Source of Monetary or Material Support  
OPD and IPD facilities and Central library of Government siddha medical College and hospital 
 
Primary Sponsor  
Name  Dr R Shanmu 
Address  II year PG scholar Department of Pura Maruthuvam, Government siddha medical College and hospital, Palayamkottai, Tirunelveli 627002 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR R Shanmu  Government siddha medical College and hospital  Department of Pura Maruthuvam, Government siddha medical College and hospital, Palayamkottai, Tirunelveli 627002
Tirunelveli
TAMIL NADU 
9500966437

vishnu31190@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTION ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  ATTAI VIDAL (external therapy)  Hirudoventralis type of leech which have a Size of 2 to 3 inches, a number of 2 to 3 leeches for 3 to 5 times for about 45 minutes to 1 hour will be applied around the affected knee joint depending upon the severity of disease. Time interval between the two Leech Application is Seven days  
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Patients having symptoms of pain in single or both knee joints, swelling, tenderness, stiffness, crepitation, restricted movements.
2.Patients who are willing to undergo Leech application
3.Willing to give specimen of blood for investigation whenever required.
4.Willing to attend OPD or admission in IPD for 48days.
5.Willing to take photograph before and after treatment.
 
 
ExclusionCriteria 
Details  1.History of Tuberculosis
2.History of Hepatitis B, AIDS, syphilis.
3.History of Heamophilia& Anticoagulant treatment
4.Pregnancy & lactation
5.Rheumatoid and other types of arthritis
6.Benign and malignant neoplasm
7.Trauma, Fracture, Ligament injury
8.Immuno compromised Patients
9.History of Psychiatric disorder
10.Surgery of the affected knee joint during the previous 3 month or joint replacement.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
reduction in severity of joint pain, stiffness, tenderness & swelling  2weeks 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is an open labelled non randomized phase II clinical trial to evaluate the efficacy of attaividal (leech therapy in siddha external therapy) in the management of azhal keel vayu(Osteoarthritis).The primary objective is to evaluate the improvement of clinical signs & symptoms in azhal keel vayu (osteoarthritis)patients before and after treatment of leech therapy . Hirudoventralis (leech) which have a size of 2 to 3 inches, in a number of 2 to 3
leeches for 3 to 5 sittings (based on severity of disease) for about 45 minutes to 1 hour will be introduced around the affected knee joint. Time
interval between the first and next consecutive leech therapy application session will be Seven days.In case of any adverse events (AE) is noticed, it will be referred to pharmacovigilence department and Further
management of patients will be given in OPD.
 
Close